Search

Your search keyword '"Asami, Shinya"' showing total 17 results
Start Over Author "Asami, Shinya" Publication Year Range Last 10 years
17 results on '"Asami, Shinya"'

2. Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06)

Author

Kimura, Yutaka, Fujii, Masashi, Masuishi, Toshiki, Nishikawa, Kazuhiro, Kunisaki, Chikara, Matsusaka, Satoshi, Segawa, Yoshihiko, Nakamura, Masato, Sasaki, Kinro, Nagao, Narutoshi, Hatachi, Yukimasa, Yuasa, Yasuhiro, Asami, Shinya, Takeuchi, Masahiro, Furukawa, Hiroshi, Nakajima, Toshifusa, and on behalf of the JACCRO GC-06 Study Group

Published
2018
Full Text
View/download PDF

6. Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC‑06)

Author

Kimura, Yutaka, Fujii, Masashi, Masuishi, Toshiki, Nishikawa, Kazuhiro, Kunisaki, Chikara, Matsusaka, Satoshi, Segawa, Yoshihiko, Nakamura, Masato, Sasaki, Kinro, Nagao, Narutoshi, Hatachi, Yukimasa, Yuasa, Yasuhiro, Asami, Shinya, Takeuchi, Masahiro, Furukawa, Hiroshi, Nakajima, Toshifusa, and on behalf of the JACCRO GC-06 Study Group

Published
2018
Full Text
View/download PDF

8. Survival results of a multicenter phase II study of trastuzumab with S-1 alone in elderly patients with HER-2 positive advanced gastric cancer (JACCRO GC-06).

Author

Nishikawa, Kazuhiro, primary, Kimura, Yutaka, additional, Masuishi, Toshiki, additional, Kunisaki, Chikara, additional, Matsusaka, Satoshi, additional, Segawa, Yoshihiko, additional, Nakamura, Masato, additional, Sasaki, Kinro, additional, Nagao, Narutoshi, additional, Hatachi, Yukimasa, additional, Yuasa, Yasuhiro, additional, Asami, Shinya, additional, Takeuchi, Masahiro, additional, Furukawa, Hiroshi, additional, Fujii, Masashi, additional, and Nakajima, Toshifusa, additional

Published
2017
Full Text
View/download PDF

9. Usefulness of a CT-guided hookwire marking in laparoscopic partial hepatectomy for hepatocellular carcinoma invisible on ultrasonography

Author

Monden, Kazuteru, primary, Sadamori, Hiroshi, additional, Hioki, Masayoshi, additional, Nakano, Kanyu, additional, Asami, Shinya, additional, Ohno, Satoshi, additional, Sasaki, Kyo, additional, Ueki, Toru, additional, Yabushita, Kazuhisa, additional, Uka, Mayu, additional, Hyodo, Tsuyoshi, additional, Sakaguchi, Kousaku, additional, and Takakura, Norihisa, additional

Published
2017
Full Text
View/download PDF

11. Gastroenterological Surgery: Esophagus

Author

Kitagawa, Yuko, primary, Idani, Hitoshi, additional, Inoue, Haruhiro, additional, Udagawa, Harushi, additional, Uyama, Ichiro, additional, Osugi, Harushi, additional, Katada, Natsuya, additional, Takeuchi, Hiroya, additional, Akutsu, Yasunori, additional, Asami, Shinya, additional, Ishikawa, Ken, additional, Okamura, Akihiko, additional, Ono, Taiki, additional, Kato, Fumihiko, additional, Kawabata, Toshiki, additional, Suda, Koichi, additional, Takesue, Tomoko, additional, Tanaka, Tsuyoshi, additional, Tsutsui, Mai, additional, Hosoda, Kei, additional, Matsuda, Satoru, additional, Matsuda, Tatsuo, additional, Mani, Mariko, additional, and Miyazaki, Tatsuya, additional

Published
2015
Full Text
View/download PDF

12. Multicenter phase II study of trastuzumab with S-1 alone in elderly patients with HER-2 positive advanced gastric cancer (JACCRO GC-06).

Author

Masuishi, Toshiki, primary, Kawase, Tomono, additional, Nishikawa, Kazuhiro, additional, Kunisaki, Chikara, additional, Matsusaka, Satoshi, additional, Segawa, Yoshihiko, additional, Nakamura, Masato, additional, Sasaki, Kinro, additional, Nagao, Narutoshi, additional, Tsuji, Akihito, additional, Yuasa, Yasuhiro, additional, Asami, Shinya, additional, Takeuchi, Masahiro, additional, Furukawa, Hiroshi, additional, Fujii, Masashi, additional, and Nakajima, Toshifusa, additional

Published
2015
Full Text
View/download PDF

15. Laparoscopic repair of an abdominal incisional hernia above the pubis

Author

Nakano, Kanyu, primary, Idani, Hitoshi, additional, Asami, Shinya, additional, Ookawa, Hiro, additional, Yoshimoto, Masashi, additional, Ito, Atene, additional, Monden, Kazuteru, additional, Kurose, Yohei, additional, Hioki, Masayoshi, additional, Ishii, Tatsuhiro, additional, Sadamori, Hiroshi, additional, Oono, Satoshi, additional, Kin, Hitoshi, additional, and Takakura, Norihisa, additional

Published
2015
Full Text
View/download PDF

16. Multimodal Treatment With Nivolumab Contributes to Long-Term Survival in a Case of Unresectable Esophagogastric Junction Neuroendocrine Carcinoma.

Author

Hanzawa S, Asami S, Kanazawa T, Oono S, and Takakura N

Abstract

Advanced neuroendocrine carcinoma (NEC) has an extremely poor prognosis, partly explained by the rarity and diagnostic difficulty, for which the most appropriate treatment strategy has not been established. In this report, we discuss a case of unresectable advanced esophagogastric junction NEC, which was difficult to diagnose, that has achieved relatively long-term survival with multidisciplinary treatment centered on nivolumab. A man in his 60s was initially diagnosed with an advanced esophagogastric junction squamous cell carcinoma (SCC). The lymph node metastasis was detected in the regional lymph nodes and para-aortic region. We diagnosed the patient with T3, N3, M1 (Lym), stage IVB, and administered systemic chemotherapy. Due to the failure of first-line, fluorouracil, and cisplatin therapy, we administered nivolumab as the second-line therapy. This therapy demonstrated partial response, so we performed conversion surgery, however the postoperative diagnosis was NEC. Three years after treatment initiation, a single lymph node metastasis has recurred, which is under control with nivolumab and radiation therapy. However, 4.5 years after the start of treatment, with the advent of immune-related adverse events (irAE), nivolumab was discontinued and the patient was placed on surveillance. Six months after that, metastasis to the hilar lymph node and adrenal gland was observed. Both times that recurrence/metastasis appeared, they occurred while nivolumab was being discontinued, suggesting its significant systemic anti-cancer effect. Therefore, nivolumab in particular may be an effective treatment for advanced esophageal NEC, and this case suggests that it may contribute to prolonged progression-free survival., Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Hanzawa et al.)

Published
2024
Full Text
View/download PDF

17. [Case of Gastric Malignant Lymphoma Invading Other Organs with Bleeding Treated by Surgery].

Author

Kanazawa T, Asami S, Kagoura M, Kadowaki D, Oshima K, Miura N, Ishikawa W, Monden K, Kurose Y, Hioki M, Kambara T, Sadamori H, Oono S, and Takakura N

Subjects
Duodenum, Female, Gastrectomy, Hemorrhage, Humans, Lymphoma, Non-Hodgkin, Stomach Neoplasms drug therapy, Stomach Neoplasms surgery
Abstract

A female in her late 50s experienced dyspnea and was transported by an ambulance. Her hemoglobin score was low, and CT imaging showed a giant tumor in her stomach. The tumor perforated her liver and invaded the abdominal wall and duodenum around the Treitz ligament. She required surgery because of the massive hemorrhage due to the tumor. Total gastrectomy with lateral segmentectomy of the liver and resection of the duodenum and the ileum around the Treitz ligament were performed. At 1.5 months after surgery, chemotherapy for malignant lymphoma was successfully initiated.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results